Terms: = Colorectal cancer AND FOXP1, MGC12942, 27086, ENSG00000114861, hFKH1B, MGC99551, FLJ23741, QRF1, 12CC4, HSPC215, MGC88572 AND Treatment
5 results:
1. MYC-Induced Upregulation of Lncrna ELFN1-AS1 Contributes to Tumor Growth in colorectal cancer via Epigenetically Silencing TPM1.
Li C; Hong S; Hu H; Liu T; Yan G; Sun D
Mol Cancer Res; 2022 Nov; 20(11):1697-1708. PubMed ID: 35857351
[TBL] [Abstract] [Full Text] [Related]
2. colorectal cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
Front Immunol; 2021; 12():778329. PubMed ID: 34975867
[TBL] [Abstract] [Full Text] [Related]
3. Altered Expression of MBNL Family of Alternative Splicing Factors in colorectal cancer.
Navvabi N; Kolikova P; Hosek P; Zitricky F; Navvabi A; Vycital O; Bruha J; Palek R; Rosendorf J; Liska V; Pitule P
Cancer Genomics Proteomics; 2021; 18(3):295-306. PubMed ID: 33893082
[TBL] [Abstract] [Full Text] [Related]
4. Upregulation of mtSSB by interleukin-6 promotes cell growth through mitochondrial biogenesis-mediated telomerase activation in colorectal cancer.
Wang G; Wang Q; Huang Q; Chen Y; Sun X; He L; Zhan L; Guo X; Yin C; Fang Y; He X; Xing J
Int J Cancer; 2019 May; 144(10):2516-2528. PubMed ID: 30415472
[TBL] [Abstract] [Full Text] [Related]
5. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.
Vanacker L; Smeets D; Hoorens A; Teugels E; Algaba R; Dehou MF; De Becker A; Lambrechts D; De Greve J
Anticancer Res; 2014 Oct; 34(10):5517-21. PubMed ID: 25275049
[TBL] [Abstract] [Full Text] [Related]
